Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Preferred Dividend Payments: 2011-2013

Historic Preferred Dividend Payments for Enanta Pharmaceuticals (ENTA) over the last 3 years, with Sep 2013 value amounting to $13.7 million.

  • Enanta Pharmaceuticals' Preferred Dividend Payments rose 130.48% to $1.2 million in Q1 2013 from the same period last year, while for Mar 2013 it was $16.4 million, marking a year-over-year change of. This contributed to the annual value of $13.7 million for FY2013, which is 6.77% down from last year.
  • As of FY2013, Enanta Pharmaceuticals' Preferred Dividend Payments stood at $13.7 million, which was down 6.77% from $14.7 million recorded in FY2012.
  • In the past 5 years, Enanta Pharmaceuticals' Preferred Dividend Payments ranged from a high of $16.3 million in FY2011 and a low of $13.7 million during FY2013.
  • Over the past 3 years, Enanta Pharmaceuticals' median Preferred Dividend Payments value was $14.7 million (recorded in 2012), while the average stood at $14.9 million.
  • Data for Enanta Pharmaceuticals' Preferred Dividend Payments shows a maximum YoY decreased of 9.99% (in 2012) over the last 5 years.
  • Enanta Pharmaceuticals' Preferred Dividend Payments (Yearly) stood at $16.3 million in 2011, then declined by 9.99% to $14.7 million in 2012, then decreased by 6.77% to $13.7 million in 2013.